Clal Insurance’s Pfizer PFE Stock Holding History

Clal Insurance’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.7M	Sell	2,234,000 -38,000	-2%	-$1.01M	0.38%	53
2025 Q4	$56.6M	Hold	2,272,000	–	–	0.36%	57
2025 Q3	$57.9M	Hold	2,272,000	–	–	0.44%	52
2025 Q2	$55.1M	Sell	2,272,000 -410	-0%	-$9.56K	0.54%	49
2025 Q1	$57.6M	Hold	2,272,410	–	–	0.6%	44
2024 Q4	$60.3M	Sell	2,272,410 -7,000	-0.3%	-$190K	0.54%	43
2024 Q3	$66M	Hold	2,279,410	–	–	0.58%	44
2024 Q2	$63.8M	Sell	2,279,410 -37,590	-2%	-$1.03M	0.67%	37
2024 Q1	$64.3M	Hold	2,317,000	–	–	0.72%	37
2023 Q4	$66.7M	Hold	2,317,000	–	–	0.87%	31
2023 Q3	$76.9M	Sell	2,317,000 -380,000	-14%	-$13.4M	1.07%	21
2023 Q2	$98.9M	Buy	2,697,000 +1,026,776	+61%	+$40M	1.18%	23
2023 Q1	$68.1M	Buy	1,670,224 +1,655,224	+11,035%	+$71.5M	1.02%	30
2022 Q4	$769K	Hold	15,000	–	–	0.01%	131
2022 Q3	$656K	Buy	+15,000	New	+$729K	0.01%	131
2016 Q3	–	Sell	-94,898	Closed	-$3.17M	–	109
2016 Q2	$3.17M	Sell	94,898 -187,629	-66%	-$5.99M	0.08%	75
2016 Q1	$7.95M	Sell	282,527 -961,657	-77%	-$27.5M	0.23%	59
2015 Q4	$38.1M	Buy	1,244,184 +69,564	+6%	+$2.19M	1.02%	28
2015 Q3	$35M	Hold	1,174,620	–	–	0.91%	26
2015 Q2	$37.4M	Hold	1,174,620	–	–	0.86%	29
2015 Q1	$38.8M	Sell	1,174,620 -70,470	-6%	-$2.24M	0.89%	28
2014 Q4	$36.8M	Buy	+1,245,090	New	+$35.7M	0.88%	34

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Clal Insurance's PFE Position: Q1 2026 in Review

Clal Insurance reduced its Pfizer (PFE) stake by 1.7% in Q1 2026, selling an estimated $1.01M and leaving 2,234,000 shares worth $62.7M. The position accounts for 0.38% of the portfolio, ranked #53.

Clal Insurance first reported a position in PFE in Q4 2014 and has held it in 22 quarters since. The position peaked at $98.9M in Q2 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Clal Insurance held 2,234,000 shares of Pfizer worth $62.7M as of Q1 2026.
Clal Insurance sold 38,000 Pfizer shares in Q1 2026, an estimated $1.01M.
Pfizer made up 0.38% of Clal Insurance's portfolio in Q1 2026, its #53 holding.
Clal Insurance first reported a position in Pfizer in Q4 2014 and has held it in 22 quarters since.
Clal Insurance's Pfizer position peaked at $98.9M in Q2 2023.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Clal Insurance's 13F filing for Q1 2026, filed 12 May 2026.